Skip to main content
Premium Trial:

Request an Annual Quote

Bruker CEO to Provide Details of Reorganization at Upcoming Investor Conference

This article has been updated from an earlier version to include details from spokesman.


NEW YORK, Sept. 10 (GenomeWeb News) - Frank Laukien, president and CEO of Bruker BioSciences, is expected to provide details of his company's recently announced reorganization at next week's Bear Stearns healthcare conference, according to a company spokesman.

Earlier today, Bruker said it has laid off around 60 employees worldwide as it tries to rein in "creeping" expenses. The company also said it has "reorganized various production, research and development, sales and administration functions" to help save additional money. The move is expected to save the company $6 million in the fourth quarter of this year, and for the whole of 2005.


Bruker "had some bottom-line set-backs and expense creep recently, which we intend to counter with this additional cost-cutting program that has affected all of our operating companies and geographies," Laukien said in a statement.


Laukien is scheduled to speak at Eastern Standard Time on Monday, Sept. 13. The presentation will be webcast on  Bruker's website.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.